Article

Timing Matters: Overall Treatment Time, Radiotherapy Interruptions, and Outcomes in glioblastomas – Prognostic Significance in Different Biological Sub- Groups

2025-07-23

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> Glioblastoma (GBM) is the most common and aggressive primary malignant brain tumor in adults, with a median overall survival (OS) rarely exceeding 15 months despite multimodal therapy. While established prognostic factors include age, Karnofsky Performance Status (KPS), and molecular features such as MGMT promoter methylation and IDH mutation status, increasing...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: af0397a9-7b73-598d-bf03-dbc9c7fa9fd2
DOI: 10.21203/rs.3.rs-7156531/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Timing Matters: Overall Treatment Time, Radiotherapy Interruptions, and Outcomes in glioblastomas – Prognostic Significance in Different Biological Sub- GroupsDOI 10.21203/rs.3.rs-7156531/v1Read

Impact of delays in initiating postoperative chemoradiation while determining the MGMT promoter-methylation statuses of patients with primary glioblastomaSemantic proximity Read

Clinical Characteristics, Treatment Outcomes, And Genetic Alterations of Radiation-Induced GliomasSemantic proximity Read

Overview of prognostic factors in adult glioma; a 10-year experience at a single institutionSemantic proximity Read

Old Does Not Necessarily Mean Worse: Standard 6-Week Chemoradiation For Elderly Patients (≥ 70 Years) With Newly Diagnosed GlioblastomaSemantic proximity Read

Real-World Survival Outcomes After (Chemo)radiotherapy for WHO 2021-Classified Gliomas: A Multicenter Analysis of Clinical, Treatment-Related, Dosimetric, and Hematologic Prognostic FactorsSemantic proximity Read

Efficacy and Survival Analysis of Long-term Temozolomide Chemotherapy for GlioblastomaSemantic proximity Read

Changes in clinical management of diffuse IDH-mutated lower-grade gliomas: patterns of care in a 15-year period.Semantic proximity Read

Age-stratified clinical performance and survival of patients with IDH-wildtype glioblastoma homogeneously treated by radiotherapy with concomitant and maintenance temozolomide.Semantic proximity Read

The prognosis of gliomas with different molecular subtypes in the era of intensity-modulated radiation therapy (IMRT).Semantic proximity Read

Old Does Not Necessarily Mean Worse: Standard Stupp Regimen for Elderly Patients (≥ 70 years) with Newly Diagnosed GlioblastomaSemantic proximity Read

Over one year of survival difference between distinct cohorts of glioblastoma patientsSemantic proximity Read

Very Late Recurrence of Glioblastoma after 8 Years of Progression-Free Survival: A Case Report and Review of Tumor DormancySemantic proximity Read